Last 48 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -7.37 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 5.67 | 7.83 | 12.24 | 5.54 | 9.30 | 17.48 | 9.15 | 9.71 | 13.37 | 9.52 | 4.71 | 5.66 | 6.14 | 5.35 | 7.48 | 9.55 | 10.04 | 12.33 | 15.05 | 12.25 | 14.75 |
| — | -55.2% | +33.7% | -42.9% | -30.4% | +83.6% | +94.3% | +71.4% | +117.8% | +77.8% | -37.0% | -40.7% | -38.8% | -56.6% | -50.3% | -22.1% | -32.0% | -43.6% | -50.0% | -50.4% | -17.5% | |
| P/B Ratio | 8.69 | 13.87 | 49.43 | 14.27 | 13.82 | 39.02 | 17.09 | 16.49 | 16.37 | 10.67 | 4.61 | 5.00 | 7.90 | 5.12 | 6.49 | 6.37 | 5.63 | 6.36 | 7.31 | 5.39 | 5.18 |
| — | -64.4% | +189.2% | -13.5% | -15.6% | +265.9% | +270.9% | +229.5% | +107.3% | +108.2% | -29.0% | -21.4% | +40.2% | -19.5% | -11.2% | +18.1% | +8.7% | -29.8% | -14.7% | -40.5% | -95.4% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.4% | 58.5% | 63.6% | 62.2% | 61.5% | 63.2% | 60.3% | 60.5% | 61.3% | 59.7% | 63.5% | 59.2% | 58.9% | 56.8% | 52.5% | 58.9% | 64.1% | 71.5% | 62.6% | 64.2% | 76.8% |
| — | -7.5% | +5.4% | +2.9% | +0.4% | +5.9% | -5.0% | +2.1% | +4.0% | +5.1% | +20.8% | +0.5% | -8.1% | -20.5% | -16.1% | -8.2% | -16.6% | +7.5% | -6.7% | -1.0% | +25.0% | |
| Operating Margin | -65.4% | -52.4% | -94.2% | -69.9% | -67.7% | -59.5% | -61.6% | -72.6% | -72.1% | -63.7% | -60.3% | -55.4% | -69.1% | -85.0% | -119.8% | -105.1% | -86.4% | -73.7% | -80.8% | -76.8% | -93.0% |
| — | +11.9% | -52.8% | +3.8% | +6.2% | +6.5% | -2.2% | -31.1% | -4.4% | +25.1% | +49.7% | +47.3% | +20.0% | -15.2% | -48.2% | -36.9% | +7.1% | +11.3% | +19.0% | -41.9% | -52.6% | |
| Net Margin | -69.1% | -61.8% | -104.2% | -78.8% | -74.8% | -66.5% | -63.3% | -71.0% | -69.3% | -61.2% | -56.1% | -54.3% | -67.8% | -83.5% | -118.5% | -103.2% | -84.8% | -73.6% | -82.8% | -78.7% | -96.9% |
| — | +7.1% | -64.5% | -10.9% | -7.9% | -8.6% | -12.9% | -30.9% | -2.2% | +26.6% | +52.7% | +47.4% | +20.0% | -13.4% | -43.2% | -31.2% | +12.5% | +15.4% | +24.5% | -25.0% | -127.6% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -95.6% | -39.2% | -76.6% | -40.8% | -35.5% | -33.1% | -29.4% | -26.6% | -19.8% | -16.3% | -13.2% | -14.9% | -20.4% | -18.7% | -23.5% | -16.1% | -11.4% | -9.2% | -9.7% | -8.4% | -8.9% |
| — | -18.6% | -160.5% | -53.5% | -79.1% | -103.3% | -122.4% | -78.6% | +3.0% | +12.9% | +43.8% | +7.9% | -78.6% | -103.8% | -141.9% | -92.8% | -27.9% | -6.0% | -19.4% | +23.5% | +92.9% | |
| ROA | -37.3% | -7.5% | -12.6% | -10.0% | -9.8% | -9.6% | -12.6% | -17.4% | -13.6% | -10.7% | -8.3% | -8.6% | -10.7% | -10.5% | -14.4% | -10.6% | -7.7% | -6.4% | -7.1% | -6.2% | -6.2% |
| — | +21.8% | -0.2% | +42.6% | +27.4% | +10.8% | -51.3% | -102.1% | -27.1% | -2.0% | +42.4% | +18.8% | -37.9% | -63.7% | -104.3% | -70.6% | -25.3% | -13.8% | -38.1% | -27.1% | -0.3% | |
| ROIC | -73.7% | -9.5% | -16.7% | -14.6% | -19.7% | -29.3% | -34.5% | -46.5% | -42.1% | -32.0% | -27.1% | -25.3% | -27.4% | -25.3% | -28.2% | -19.5% | -12.3% | -8.8% | -15.9% | -38.1% | -43.9% |
| — | +67.6% | +51.7% | +68.6% | +53.3% | +8.7% | -27.2% | -83.8% | -53.5% | -26.5% | +4.0% | -29.6% | -122.4% | -187.1% | -77.5% | +48.8% | +71.9% | +79.5% | +59.5% | -49.0% | -28.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.08 | 2.70 | 5.93 | 3.37 | 2.08 | 2.25 | 1.80 | 0.17 | 0.14 | 0.13 | 0.43 | 0.40 | 0.66 | 0.58 | 0.52 | 0.36 | 0.32 | 0.30 | 0.28 | 0.27 | 0.25 |
| — | +20.0% | +230.4% | +1862.1% | +1378.8% | +1667.8% | +318.2% | -57.2% | -78.7% | -78.1% | -17.5% | +10.4% | +102.6% | +94.1% | +84.7% | +36.7% | +29.1% | -34.4% | -33.0% | -57.1% | -97.5% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 5.91 | 6.76 | 4.73 | 5.79 | 5.91 | 6.37 | 7.30 | 3.53 | 3.22 | 4.54 | 2.79 | 3.13 | 4.87 | 6.68 | 6.56 | 7.60 | 7.54 | 8.83 | 10.33 | 14.60 | 13.02 |
| — | +6.1% | -35.3% | +64.1% | +83.3% | +40.3% | +161.7% | +12.8% | -33.8% | -31.9% | -57.5% | -58.8% | -35.4% | -24.4% | -36.5% | -48.0% | -42.1% | -37.7% | -33.9% | -35.3% | +63.7% | |
| Quick Ratio | 5.13 | 5.77 | 3.87 | 4.88 | 5.13 | 5.56 | 6.45 | 2.57 | 2.56 | 3.61 | 2.31 | 2.60 | 3.80 | 5.07 | 5.08 | 5.98 | 6.17 | 7.47 | 9.12 | 13.16 | 11.98 |
| — | +3.8% | -40.0% | +90.2% | +100.5% | +53.9% | +179.4% | -1.3% | -32.7% | -28.8% | -54.6% | -56.5% | -38.3% | -32.2% | -44.3% | -54.6% | -48.5% | -43.9% | -38.4% | -38.8% | +72.5% | |
| Interest Coverage | -9.67 | -4.38 | -7.25 | -5.91 | -10.07 | -9.83 | -71.65 | — | — | — | — | — | — | — | — | — | — | — | -46.20 | -36.45 | -24.30 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CLPT stock.
ClearPoint Neuro, Inc.'s current P/E is -7.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
ClearPoint Neuro, Inc.'s current operating margin is -65.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking ClearPoint Neuro, Inc.'s business trajectory between earnings reports.